Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Related Concept Videos

Inborn Errors of Metabolism

Inborn Errors of Metabolism

Phenylketonuria (PKU) is a protein metabolism disorder characterized by high blood levels of the amino acid phenylalanine. This results from a mutation in the gene responsible for phenylalanine hydroxylase, an enzyme that converts phenylalanine into tyrosine. When this enzyme is deficient, phenylalanine builds up in the blood, leading to symptoms such as vomiting, rashes, seizures, growth deficiency, and severe mental retardation. An early diagnosis and a diet restricting phenylalanine intake...

Teratogenicity

Teratogenicity

The ability of a drug to produce structural deformations and functional abnormalities in the developing embryo or the fetus is called teratogenicity, and the drug producing this effect is known as a teratogen. Teratogenic effects include stillbirth, miscarriage, intrauterine growth restriction, and neurocognitive delay. A teratogen may affect the embryo at different stages of development, which is important in determining the type and extent of the damage. During blastocyst formation, the early...

Protein Import into the Peroxisomes

Protein Import into the Peroxisomes

Cells contain membrane-bound organelles called peroxisomes that oxidize organic molecules by transferring hydrogen atoms to oxygen, producing hydrogen peroxide. Peroxisomes enzymatically convert the released hydrogen peroxide into water and oxygen.
Peroxisomal Protein Import:
Peroxisomes lack the genetic machinery required to code for their own proteins. Hence, most peroxisomal membrane, lumenal and transmembrane proteins are synthesized in the cytoplasm or ER and transported to the peroxisome...

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Pharmacogenetics of Phase I Enzymes: Cytochrome P450 Isozymes

Cytochrome P450 (CYP450) enzymes are a superfamily of heme-containing monooxygenases that play a pivotal role in Phase I drug metabolism by catalyzing oxidation and reduction reactions.These enzymes transform lipophilic xenobiotics into more hydrophilic metabolites, facilitating subsequent Phase II conjugation and eventual excretion. The CYP450 family is classified into families (e.g., CYP1–CYP3) and subfamilies (e.g., CYP2A, CYP2C), based on amino acid sequence homology.CYP450 isoenzymes,...

Biosynthesis of Nucleic Acids

Biosynthesis of Nucleic Acids

Nucleic acid biosynthesis is a fundamental biochemical process that produces the purine and pyrimidine nucleotides essential for DNA and RNA synthesis. This pathway maintains a balanced nucleotide pool, preventing imbalances that could jeopardize genetic integrity and cellular function. Given the crucial role of nucleotides, their synthesis is tightly regulated to ensure proper cellular homeostasis.Purine BiosynthesisThe biosynthesis of purine nucleotides begins with ribose-5-phosphate, a...

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Pharmacogenetic Phenotypes: Alterations in Pharmacokinetics, Drug Targets and Biologic Milieu

Genetic variations significantly influence drug response through pharmacokinetics, receptor interactions, and biologic milieu modifications. Pharmacokinetic alterations impact drug metabolism and clearance, affecting efficacy and toxicity. Variants in drug-metabolizing enzymes, such as CYP2C9 and CYP2C19, alter drug activation and elimination. For example, CYP2C9 loss-of-function variants require lower warfarin doses to prevent excessive bleeding, while CYP2C19 variants reduce clopidogrel...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Tisotumab vedotin in Japanese patients with recurrent or metastatic cervical cancer: results from the innovaTV 301/ENGOT-cx12/GOG-3057 trial.

International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2026

Same author

[Chemotherapy for Epithelial Ovarian, Fallopian Tube, and Primary Peritoneal Cancer].

Gan to kagaku ryoho. Cancer & chemotherapy·2025

Same author

Oncologists' Views and Communication Practices Regarding Unproven High-Cost Cancer Interventions in Private Medical Practice: A Questionnaire Survey.

Cancer control : journal of the Moffitt Cancer Center·2025

Same author

High-Dose Corticosteroid Therapy in Facial Nerve Palsy: A Retrospective Study.

Cureus·2025

Same author

Unapproved and unproven cancer treatments in patients admitted to palliative care units.

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer·2024

Same author

Interstitial lung disease with prolonged fever that occurred during long-term administration of olaparib in a 74-year-old ovarian cancer patient: Radiological features and considerations for preventing delayed diagnosis.

Radiology case reports·2024

Search research articles

Related Experiment Video

Updated: May 15, 2026

Quantification of Coenzyme A in Cells and Tissues

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

Genetic defects in pregnenolone synthesis.

Noriyuki Katsumata¹

¹Division of Basic Endocrine Research, Department of Molecular Endocrinology, National Research Institute for Child Health and Development, Tokyo, Japan. katsumata-n@ncchd.go.jp

Pediatric Endocrinology Reviews : PER

|January 22, 2013

Summary

Pregnenolone synthesis defects can cause severe congenital adrenal hyperplasia. Pathophysiological diagnoses like StAR or SCC deficiency are more precise than histopathological diagnoses such as CLAH.

More Related Videos

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Prostaglandin Extraction and Analysis in Caenorhabditis elegans

Prostaglandin Extraction and Analysis in Caenorhabditis elegans

Published on: June 25, 2013

Related Experiment Videos

Last Updated: May 15, 2026

Quantification of Coenzyme A in Cells and Tissues

Quantification of Coenzyme A in Cells and Tissues

Published on: September 27, 2019

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

A Novel Strategy Combining Array-CGH, Whole-exome Sequencing and In Utero Electroporation in Rodents to Identify Causative Genes for Brain Malformations

Published on: December 1, 2017

Prostaglandin Extraction and Analysis in Caenorhabditis elegans

Prostaglandin Extraction and Analysis in Caenorhabditis elegans

Published on: June 25, 2013

Area of Science:

Endocrinology
Genetics
Biochemistry

Background:

Pregnenolone synthesis is crucial for all steroid hormone production.
Disruptions lead to congenital lipoid adrenal hyperplasia (CLAH), a severe condition.
Mutations in the STAR gene were initially linked to CLAH.

Purpose of the Study:

To clarify genetic and phenotypic variations in pregnenolone synthesis defects.
To differentiate between STAR and CYP11A1 gene mutations.
To propose more precise diagnostic terminology.

Main Methods:

Review of genetic and phenotypic data related to pregnenolone synthesis defects.
Analysis of mutation impacts on steroidogenesis.
Comparison of diagnostic approaches.

Main Results:

Mutations in CYP11A1 (cholesterol side-chain cleavage enzyme) also disrupt pregnenolone synthesis.
STAR mutations do not always manifest as typical CLAH.
Pathophysiological diagnoses offer greater precision.

Conclusions:

STAR deficiency and SCC deficiency are more accurate pathophysiological diagnoses.
These diagnoses are preferable to histopathological diagnoses like CLAH for clarity.
Precise diagnosis is essential for understanding and managing steroidogenesis disorders.